The current pandemic is highlighting and widening inequities in health systems globally. Effectively tackling COVID-19 and its repercussions requires a comprehensive, coordinated global response. We welcome the recognition of key vulnerable groups including those with pre-existing conditions like cancer and other NCDs within the proposed resolution on the global COVID-19 response.
Recent Publications – Essential Medicines Working group
Barr R, Robertson J (2016). Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries. Pediatric Blood and Cancer 63(2): 287-291. Denburg AE, Knaul FM, Atun R, Frazier LA and Barr RD (2014). Beyond the bench and the bedside: Economic and health system dimensions of global childhood cancer outcomes. […]